gi pathology in immunosuppressed patients

86
GI pathology in immunosuppressed patients Newton ACS Wong Department of Cellular Pathology Southmead Hospital Bristol

Upload: others

Post on 02-May-2022

6 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: GI pathology in immunosuppressed patients

GI pathology in

immunosuppressed

patients

Newton ACS Wong

Department of Cellular Pathology

Southmead Hospital

Bristol

Page 2: GI pathology in immunosuppressed patients

Which “immunosuppressed

patients” ?•HIV/AIDS patients

•Therapeutic immunosuppression

– Oncology treatment

– Transplantation:

•Solid organ

•Bone marrow

•[Not primary

immunodeficiencies]

Page 3: GI pathology in immunosuppressed patients
Page 4: GI pathology in immunosuppressed patients

Talk plan

•Diseases common to several

immunosuppressed groups

– Infection

– Neoplasia

– Drugs

•Diseases specific to certain

immunosuppressed groups

Page 5: GI pathology in immunosuppressed patients

Infection

•Bacteria

– Infectious colitides

Page 6: GI pathology in immunosuppressed patients
Page 7: GI pathology in immunosuppressed patients
Page 8: GI pathology in immunosuppressed patients
Page 9: GI pathology in immunosuppressed patients
Page 10: GI pathology in immunosuppressed patients

ZN+, thus: Mycobacteria

Page 11: GI pathology in immunosuppressed patients

PAS +ve

Page 12: GI pathology in immunosuppressed patients

2. 23M. MSM. 10 cms long stricture in rectum and anus, clinically & radiologically

malignant. The surgeon was sharpening his scalpel in the MDTM helped by the

usual confidently expressed diagnosis by the radiologist. A total of 20 separate

biopsies, in two settings, showed fibrinopurulent exudate, granulation tissue and

inflamed fibromuscular connective tissue with no mucosa, no granulomas and no

tumour.

Coronal and sagittal MRI images of the pelvis

Page 13: GI pathology in immunosuppressed patients

2. This is before and after treatment, with eight weeks separating them. Note the

massively thickened rectum before treatment (left) and the normal calibre rectum

after treatment (right). What’s the diagnosis and what was the treatment?

Page 14: GI pathology in immunosuppressed patients

32 year old male presented bloody diarrhoea

? IBD

Page 15: GI pathology in immunosuppressed patients

Same patient 8 weeks later

Page 16: GI pathology in immunosuppressed patients

Soni S, Srirajaskanthan R, Lucas SB, Alexander S, Wong T, White JA.

Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease

in 12 homosexual men. Aliment Pharmacol Ther. 2010 Jul;32(1):59-65.

Page 17: GI pathology in immunosuppressed patients

Viruses

Page 18: GI pathology in immunosuppressed patients

Herpes simplex virus

Page 19: GI pathology in immunosuppressed patients

71 female with

heartburn.

Previous hx of

resected CRC.

OGD: Severe

oesophagitis

Page 20: GI pathology in immunosuppressed patients
Page 21: GI pathology in immunosuppressed patients

CMV oesophagitis

(Patient was receiving

5FU-based chemoRx)

Page 22: GI pathology in immunosuppressed patients

CMV •HIV/AIDS, transplant and chemoRx

patients:

– Inflammation and viral inclusions

– Crypt apoptosis alone

Page 23: GI pathology in immunosuppressed patients

Sigmoid colonic tumour

Page 24: GI pathology in immunosuppressed patients

Biopsies of sigmoid colonic tumour

Page 25: GI pathology in immunosuppressed patients
Page 26: GI pathology in immunosuppressed patients

CMV •HIV/AIDS, transplant and chemoRx

patients:

– Inflammation and viral inclusions

– Crypt apoptosis alone

– Present as a focal lesion

Page 27: GI pathology in immunosuppressed patients
Page 28: GI pathology in immunosuppressed patients
Page 29: GI pathology in immunosuppressed patients

Adenovirus

Page 30: GI pathology in immunosuppressed patients

Viruses

•EBV – PTLD and smooth muscle

tumours

•HHV8 – Kaposi sarcoma

•HPV – anal squamous

neoplasia

Page 31: GI pathology in immunosuppressed patients

Fungi and parasites

Page 32: GI pathology in immunosuppressed patients
Page 33: GI pathology in immunosuppressed patients

Cryptosporidia

Page 36: GI pathology in immunosuppressed patients
Page 37: GI pathology in immunosuppressed patients

Leishmania

Page 38: GI pathology in immunosuppressed patients

Neoplasia

•Lymphoid

•Epithelial

•Mesenchymal

Page 39: GI pathology in immunosuppressed patients

Epstein Barr virus &

Post-transplant

lymphoproliferative disease

(PTLD)

•Solid organ >> bone marrow

Page 40: GI pathology in immunosuppressed patients

Monomorphic PTLD

Page 41: GI pathology in immunosuppressed patients

Monomorphic PTLD

CD20 EBER

Page 42: GI pathology in immunosuppressed patients

Polymorphic PTLD

Page 43: GI pathology in immunosuppressed patients

Polymorphic PTLD

CD20 EBER

Page 44: GI pathology in immunosuppressed patients

Polymorphic PTLD

EBER

Page 45: GI pathology in immunosuppressed patients

Polymorphic PTLD

Page 46: GI pathology in immunosuppressed patients

Polymorphic PTLD

EBER

Page 47: GI pathology in immunosuppressed patients

Neoplasia

•Lymphoid

– PTLD (polymorphic type can

mimic Crohn’s disease)

Page 48: GI pathology in immunosuppressed patients
Page 49: GI pathology in immunosuppressed patients

Neoplasia

•Lymphoid

– PTLD (polymorphic type can

mimic Crohn’s disease)

– EBV driven GIT lymphomas and

immunosuppression – e.g. IBD

– HIV and lymphomas (primary

effusion lymphoma – HHV8)

Page 50: GI pathology in immunosuppressed patients

Neoplasia

•Epithelial

– Anal squamous dysplasia and

squamous cell carcinoma

Page 51: GI pathology in immunosuppressed patients

Neoplasia •Mesenchymal

– Kaposi sarcoma (can be CD117 +ve

but is DOG1 -ve)

Page 52: GI pathology in immunosuppressed patients

• In HIV/AIDS patients, EBV driven

smooth muscle neoplasms:

– less pleomorphism

– low mitotic count

Page 53: GI pathology in immunosuppressed patients

Drugs •Diarrhoea and:

– Antiretrovirals

– Cyclosporine

– Tacrolimus

•Mycophenolate mofetil (MMF)

Page 54: GI pathology in immunosuppressed patients

MMF

•Oesophagus to Colorectum

•Histological patterns

– GvHD like

– IBD like

– Combinations

– (Dilated damaged crypts)

Page 55: GI pathology in immunosuppressed patients

MMF

Page 56: GI pathology in immunosuppressed patients

Talk plan

•Diseases common to several

immunosuppressed groups

– Infection

– Neoplasia

– Drugs

•Diseases specific to certain

immunosuppressed groups

Page 57: GI pathology in immunosuppressed patients

Gastrointestinal GvHD

•BMT rather than solid organ

transplant patients

•Hallmark histological feature is

apoptosis

– Proliferative compartments

Page 58: GI pathology in immunosuppressed patients
Page 59: GI pathology in immunosuppressed patients
Page 60: GI pathology in immunosuppressed patients

Gastrointestinal GvHD

•Can include:– Acute inflammation

– Granulomas?

Page 61: GI pathology in immunosuppressed patients

Granulomas in GI GvHD?

Page 62: GI pathology in immunosuppressed patients
Page 63: GI pathology in immunosuppressed patients

Gastrointestinal GvHD

•Other causes of apoptosis

– Conditioning drugs (< Day 21)

– Mycophenolate mofetil (MMF)

– Viruses

Page 64: GI pathology in immunosuppressed patients
Page 65: GI pathology in immunosuppressed patients

Control grp: Non-BMT patients

investigated for GI symptoms or

being followed up for colorectal

polyps

Page 66: GI pathology in immunosuppressed patients
Page 67: GI pathology in immunosuppressed patients

When assessing transplant

patient GI biopsies

•Time from transplant?

•Transplant type?

•Underlying disease?

•GvHD elsewhere?

•MMF therapy?

•CMV, Adenovirus and EBV

titres?

Page 68: GI pathology in immunosuppressed patients
Page 69: GI pathology in immunosuppressed patients
Page 70: GI pathology in immunosuppressed patients
Page 71: GI pathology in immunosuppressed patients

Granulomas in GI GvHD?

Page 72: GI pathology in immunosuppressed patients
Page 73: GI pathology in immunosuppressed patients
Page 74: GI pathology in immunosuppressed patients

Underlying condition

requiring transplant

•BMT transplant– Lymphoma/leukaemia

Page 75: GI pathology in immunosuppressed patients

Underlying condition

requiring transplant

•Renal transplant– Amyloid

Page 76: GI pathology in immunosuppressed patients

Underlying condition

requiring transplant

•Liver transplant– Portal colopathy

– Primary sclerosing cholangitis and IBD

Page 77: GI pathology in immunosuppressed patients

Transplantation and IBD

•Does transplantation improve

or worsen IBD?

Page 78: GI pathology in immunosuppressed patients
Page 79: GI pathology in immunosuppressed patients

Transplantation and IBD

•Does transplantation improve

or worsen IBD?

• Immunosuppression helps but

restoration of normal liver

function has opposite effect.

Page 80: GI pathology in immunosuppressed patients

Other specific associations

•Solid organ transplant patients

– Gastric and duodenal ulcers

Page 81: GI pathology in immunosuppressed patients

Other specific associations

•Solid organ transplant patients

– Gastric and duodenal ulcers

•HIV/AIDS patients– Oesophageal and anal ulcers

– Enterocolopathy (apoptosis and

villous atrophy)

Page 82: GI pathology in immunosuppressed patients

23M AML patient

Page 83: GI pathology in immunosuppressed patients

•Pneumatosis coli:

•Colitis but no …

Page 84: GI pathology in immunosuppressed patients

Leukaemia and

neutropaenic colitis

Page 85: GI pathology in immunosuppressed patients

Summary

•Rare and/or multiple pathology

•Clinical data are crucial –

especially when considering

GvHD

Page 86: GI pathology in immunosuppressed patients

When assessing transplant

patient GI biopsies

•Time from transplant?

•Transplant type?

•Underlying disease?

•GvHD elsewhere?

•MMF therapy?

•CMV, Adenovirus and EBV

titres?